While Washington stews over official policy, a few biotechs are creating real therapies that leverage stems cells remarkable healing capacity. Their work is just the beginning.




This article is courtesy of Stocks Down on Unusual Volume
A late-game win with Akamai | Oil hits new highs! | Grab the green real-estate boom

Add to Google
Technorati tags: footsie • footsie news • ftse • london stock exchange • new york stock exchange • stock exchange
Flickr tags: footsie • footsie news • ftse • london stock exchange • new york stock exchange • stock exchange
Tags: footsie, footsie news, ftse, london stock exchange, new york stock exchange, stock exchange
Leave a comment Send a trackback
Categories: Daily Reports
Add To My Favourites

Trackback address for this post

Trackback URL (right click and copy shortcut/link location)

No feedback yet

Leave a comment


Your email address will not be revealed on this site.

Your URL will be displayed.
(Line breaks become <br />)
(Name, email & website)
(Allow users to contact you through a message form (your email will not be revealed.)